Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL000881

Drug Information
SynonymsNaltrexone MB; methyl-naltrexone hydrobromide; C21H26NO4; CID5361918; 83387-25-1; MRZ 2663BR; LS-177749; Quaternary ammonium naltrexone; UNII-0RK7M7IABE; naltrexonium methiodide; N-Methylnaltrexone; 17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium; Mrz-2663; Methylnaltrexone; CID11639740; CID11992464; NALTREXONE METHYLBROMIDE; Methylnaltrexonium; 17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinanium-6-one; Morphinanium, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-17-methyl-6-oxo-, (5alpha)-    
CompanyWyeth and Progenics    
IndicationConstipation, Postoperative ileusPhase IV completed    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
CAS NumberCAS 83387-25-1
PubChem Compound IDCID 11992464.    
PubChem Substance IDSID 37440843.    
TargetMu-type opioid receptor Antagonist[1]
Ref 1Emerging drugs for postoperative ileus. Expert Opin Emerg Drugs. 2007 Nov;12(4):619-26. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543